Wang Yuan, Su Wei, Zhou Guangyao, Wang Yijie, Wu Chunnuan, Zhang Pengpeng, Zhang Lianmin
Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Tianjin, China.
Department of Lung Cancer, Tianjin Lung Cancer Center, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
Thorac Cancer. 2025 Aug;16(15):e70140. doi: 10.1111/1759-7714.70140.
Lung adenocarcinoma, the most common subtype of non-small cell lung cancer, faces challenges such as drug resistance and tumor heterogeneity. N4-acetylcytidine (ac4C) is an important RNA modification involved in cancer progression, but its role in lung adenocarcinoma remains unclear.
This study analyzed transcriptomic and single-cell RNA sequencing data from public databases to investigate the expression and clinical significance of ac4C-related genes in lung adenocarcinoma. Ten machine learning algorithms were applied to develop and validate an ac4C-related gene signature (ARGSig) for prognosis prediction across multiple independent cohorts.
Cells with high ac4C activity showed increased intercellular communication and activation of tumor-associated pathways. The ARGSig model effectively stratified patients by survival outcomes and predicted sensitivity to immune checkpoint inhibitors and chemotherapy agents.
ac4C modification and its related genes play a critical role in lung adenocarcinoma development. The ARGSig model provides a promising molecular tool for prognosis evaluation and personalized treatment guidance in lung adenocarcinoma patients.
肺腺癌是非小细胞肺癌最常见的亚型,面临着耐药性和肿瘤异质性等挑战。N4-乙酰胞苷(ac4C)是一种参与癌症进展的重要RNA修饰,但其在肺腺癌中的作用仍不清楚。
本研究分析了来自公共数据库的转录组和单细胞RNA测序数据,以研究ac4C相关基因在肺腺癌中的表达及临床意义。应用十种机器学习算法开发并验证了一种用于多个独立队列预后预测的ac4C相关基因特征(ARGSig)。
具有高ac4C活性的细胞显示细胞间通讯增加和肿瘤相关通路的激活。ARGSig模型有效地根据生存结果对患者进行分层,并预测对免疫检查点抑制剂和化疗药物的敏感性。
ac4C修饰及其相关基因在肺腺癌发展中起关键作用。ARGSig模型为肺腺癌患者的预后评估和个性化治疗指导提供了一种有前景的分子工具。